ABALL_ASM
0 likes112 views
Toxikon will be exhibiting at the 114th General Meeting for the American Society for Microbiology from May 18-20 in Boston. Their study director Anthony Ball will be participating in a mentoring breakfast on May 20th, where he will mentor on careers in industry. Toxikon provides microbiology services such as sterility testing, bioburden determination, and endotoxin evaluation to support product development and registration.
1 of 2
Download to read offline
Recommended
ABALL_PDA
ABALL_PDAAnthony Ball
Ìý
Anthony Ball, a study director at Toxikon Corporation, presented a poster at the 2014 PDA/FDA Virus & TSE Safety Conference on the use of bacteriophage to simulate viral ingress into sterile medical device fluid paths. The conference brought together regulators and industry professionals to discuss product safety related to viruses and transmissible spongiform encephalopathy. Mr. Ball's poster proposed a simple solution for medical device viral ingress testing using bacteriophage models.P 191-pharmaceutical microbiology
P 191-pharmaceutical microbiologyDale Butler
Ìý
The document advertises and provides an agenda for the 6th Annual Conference on Pharmaceutical Microbiology taking place January 17-19, 2017 in London. It will feature presentations and workshops on topics such as endotoxin testing, rapid microbial detection methods, environmental monitoring, and contamination control. Registration discounts are available before certain dates.Bio clad specification presentation
Bio clad specification presentationAdvanced Hygienic Contracting Ltd
Ìý
This document summarizes the services and products of a company that specializes in hygienic wall, ceiling and flooring systems for healthcare, food manufacturing, and other industries. The company has over 15 years of experience installing customized hygienic cladding systems. They offer a world-first antimicrobial cladding system called BioClad that eliminates superbugs like MRSA and E. coli. BioClad contains silver ion technology, has been independently tested to reduce bacteria and molds, and comes with a lifetime warranty.SMi Group's Superbugs & Superdrugs 2016 conference
SMi Group's Superbugs & Superdrugs 2016 conferenceDale Butler
Ìý
This document provides information on two pre-conference workshops at the "Superbugs & Superdrugs" conference on combating antimicrobial resistance.
The first workshop discusses rapid diagnostic tools for infectious diseases, focusing on tracking emerging infections, state-of-the-art diagnostic methods, mobile applications, and challenges in diagnosis.
The second workshop examines how antimicrobial copper touch surfaces can improve patient outcomes and reduce costs by lowering healthcare-associated infections and antimicrobial resistance. It will evaluate the evidence supporting copper's use and discuss cost-benefit analysis and practical implementation.P-163 Superbugs & Superdrugs
P-163 Superbugs & SuperdrugsWarka Ghirmai
Ìý
This document provides information on two pre-conference workshops at the "Superbugs & Superdrugs" conference on combating antimicrobial resistance.
The first workshop discusses rapid diagnostic tools for infectious diseases, focusing on tracking emerging infections, state-of-the-art diagnostic methods, mobile applications, and challenges in diagnosis.
The second workshop examines making materials like copper touch surfaces in healthcare settings to improve patient outcomes and reduce costs by lowering infection rates and antimicrobial resistance. It will evaluate the evidence for copper's antimicrobial efficacy and cost-benefit analysis.SMi Group's Pharmaceutical Microbiology UK 2020
SMi Group's Pharmaceutical Microbiology UK 2020Dale Butler
Ìý
This document provides information on the upcoming Pharmaceutical Microbiology UK conference in January 2020. The conference will focus on contamination control, environmental monitoring, and current regulatory expectations. It will feature speakers from pharmaceutical companies and regulatory agencies who will discuss topics such as the impact of revisions to Annex 1, strategies for effective environmental monitoring programs, and novel methods for rapid microbial detection. A post-conference workshop day will include interactive sessions on developing risk-based cleaning approaches, designing environmental monitoring programs, and rapid microbiological methods and testing.Superbugs & Superdrugs 2017
Superbugs & Superdrugs 2017Fateja Begum
Ìý
SMi is proud to present the 2017 19th annual Superbugs & Superdrugs conference, taking place on 20th and 21st March in Central London.
Expanding horizons on the growing threat of anti-microbial resistance for almost two decades, the flagship show in the global Superbugs portfolio of events will once again play host to an international audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities.VaccinesIndia-2015_Brochure
VaccinesIndia-2015_Brochurejessie casper
Ìý
The document provides information about the 8th Indo Global Summit and Expo on Vaccines & Vaccination conference being held in Hyderabad, India from November 2-4, 2015. It discusses the conference agenda, benefits of attending, supporting partners, and editorial board members. The conference will bring together over 500 participants from around the world to present and discuss research in vaccines.Biofest events organised by the Victorian Government
Biofest events organised by the Victorian GovernmentAndrew Wear
Ìý
As the State sponsor we invite registered delegates to consider attending some of the Victorian Government organised Biofest events.Microbion_nutraceuticals_emailing
Microbion_nutraceuticals_emailingAntonio Del Casale
Ìý
Microbion offers analytical, research and development, and bio-bank services for nutraceutical companies. Their services include genomic analysis of microorganisms used in probiotics and fermented foods, as well as assessing genetic stability, purity, safety, and validating health claims. Microbion can also authenticate strains using DNA fingerprinting and develop diagnostic methods and protocols tailored for specific customer strains or formulations.MRADUS16-PBCUS16_Agenda
MRADUS16-PBCUS16_AgendaKatarina Kadovic
Ìý
The document provides information about the 4th Microbiome R&D and Business Collaboration Forum and Probiotics Congress that will take place from 3-4 October 2016 in La Jolla, San Diego. The conference will explore research on the human microbiome and its role in health and disease, as well as commercial opportunities. Over 250 attendees are expected, including leading academics and industry experts who will give presentations on topics like gut and skin microbiota, probiotics, and commercializing microbiome research. The schedule provides details on speakers, session topics, sponsors, and arrangements.InfectionPrevention_AtulSingh
InfectionPrevention_AtulSinghAtul Kumar Singh, PhD
Ìý
Healthcare-associated infections are a major public health problem worldwide and a leading cause of death in hospitals. Antimicrobial resistance poses a serious threat as many antibiotics are becoming ineffective. Disinfection and sanitization are important first lines of defense against disease-causing microbes. However, research and development of new and effective disinfectants has been limited by a lack of funding and public perception of disinfectants as non-essential. Increased investment in disinfectant research and ensuring proper use and training are needed to address the growing risks of antibiotic resistance.Quality In Biopharma Press Release
Quality In Biopharma Press ReleaseStewart K. Jason
Ìý
The second annual North Carolina Quality in Biopharma Conference will be held May 20-21, 2010 at the Bioprocessing Technical Education Center at North Carolina State University's Centennial Campus in Raleigh, North Carolina. The focus of the two-day event will be environmental monitoring in biomanufacturing, with talks, discussions, and networking for professionals in quality, manufacturing, environmental microbiology, and process engineering. James C. Greenwood, president and CEO of the Biotechnology Industry Organization, will speak about how the biotechnology industry is being impacted by legislation and shaped by public policy.Pharmaceutical microbiology west coast
Pharmaceutical microbiology west coastAlia Malick
Ìý
SMi will host the 7th Pharmaceutical Microbiology West Coast conference on June 8-9, 2017 in San Diego, USA. The conference will address current challenges in sterility assurance, environmental monitoring, and rapid microbial methods. Over the two days, experts from companies like GSK, Amgen, Janssen, and Takeda will discuss topics like environmental monitoring trends and data analysis, challenges in endotoxin testing and sterility assurance, case studies on contamination control, and the validation and use of rapid microbial methods. Workshops on the day before will cover technologies for monitoring contamination control and case studies, as well as microbial requirements for terminal sterilization.2011 October - PCT News Discovery Starts With Sample Preparation
2011 October - PCT News Discovery Starts With Sample PreparationPressure BioSciences, Inc.
Ìý
This document discusses presentations made by independent researchers at scientific conferences highlighting the advantages of Pressure Cycling Technology (PCT) developed by Pressure BioSciences, Inc. It notes that PCT allows faster and improved sample processing for applications such as biomarker discovery. Pressure BioSciences believes increased awareness and acceptance of PCT will lead to increased revenue in the second half of 2011 compared to the first half. The company is working to commercialize new PCT-based instruments and raise capital to support sales and marketing efforts.SMi Group's Superbugs and Superdrugs 2020 conference
SMi Group's Superbugs and Superdrugs 2020 conferenceDale Butler
Ìý
This document provides information about the Superbugs & Superdrugs conference on March 30-31, 2020 in London. The conference will focus on non-traditional approaches to fighting antimicrobial resistance and will feature speakers from companies and organizations working on alternatives to antibiotics, including those developing antibacterial proteins, agents that neutralize bacterial virulence, direct lytic agents, and immunomodulatory therapies. It provides details on the agenda, speakers, workshops, registration and sponsorship opportunities.BeneficialMicrobes-2015_Brochure
BeneficialMicrobes-2015_BrochureJames Roberts
Ìý
This document provides information about the "Beneficial Microbes-2015" conference to be held in Valencia, Spain from August 25-27, 2015. The conference will focus on exploiting the power of microbes for industrial development. It will include presentations from experts in various fields related to beneficial microbes. Participants can attend speaker sessions, workshops, poster presentations, and networking events. The conference aims to bring together academics, industry professionals, and public health experts to discuss the latest research and applications of beneficial microbes.CHI's Immunogenicity & Bioassay Summit 2018
CHI's Immunogenicity & Bioassay Summit 2018James Prudhomme
Ìý
This document provides information about the 10th Annual Immunogenicity & Bioassay Summit taking place from October 22-25, 2018 in Washington, DC. It will include conferences on immunogenicity assessment and clinical relevance, immunogenicity prediction and control, and optimizing bioassays for biologics. There will also be a symposium on immunology for biotherapeutics and a training seminar on design of experiments. The summit brings together industry, academia, and regulatory authorities to discuss challenges in the field. It provides opportunities for networking, learning about new expectations, and hearing from thought leaders and regulators.India's first Int'l Conference on Best Practices in Pharma Microbiology 
India's first Int'l Conference on Best Practices in Pharma Microbiology Biocon
Ìý
This is the first time that Pharmig, an international Pharmaceutical Microbiology think tank based out of the UK is organizing a conference on the "Best Practices in Pharma Microbiology" for the first time in India. You can register
by sending an email to maxine@pharmig.org.uk. For booking a seat for the conference, please visit: http://bit.ly/1J4gtLhBiobanking 2010 Ta
Biobanking 2010 Tatatisalla
Ìý
The document announces a conference on biobanking to be held on February 4-5, 2010 in London. It will examine trends in the biobanking industry and address challenges in areas like ethics, regulation, and cost-effectiveness. Key speakers will discuss developing biobanks, patient involvement, and data protection. Attendees can network with leaders from pharma, biotech, healthcare, and regulatory agencies. The conference aims to provide an in-depth understanding of opportunities and advancements in biobanking.Biosimilars 2012
Biosimilars 2012Omics Publishing Group
Ìý
The International Conference and Exhibition on Biowaivers & Biosimilars will be held September 10-12, 2012 in San Antonio, Texas. The goal is to educate participants on national and international initiatives affecting biosimilar drug development and procedures to waive bioequivalence studies. Topics will include biosimilars regulation, clinical studies, commercialization, and biowaivers based on biopharmaceutics classification systems and in vitro-in vivo correlation. The conference aims to further understanding of continuous efforts to improve biosimilar quality and use of biowaivers to make bioequivalence studies more cost effective.Conferences
ConferencesOMICS Group | International Science Conferences
Ìý
OMICS Group aims at creating collaboration between the various members of the scientific community through a common platform. This enables exchange of the latest developments by delegates at the OMICS Group conference, which is split into several tracks and themes according to the requirements. The perspective of OMICS Group in organizing the events yields a common objective to meet and discuss the most happening developments in the relevant domain.National institue of biotechnology
National institue of biotechnologyAbirHasanJoy1
Ìý
The National Institute of Biotechnology (NIB) in Bangladesh has several research divisions focused on important areas:
- Environmental Biotechnology studies arsenic contamination and bioremediation.
- Microbial Biotechnology develops enzymes for industries and studies diseases.
- Plant Biotechnology works on crops and detects potato diseases.
- Molecular Biotechnology examines human diseases like diabetes.
The NIB was established in 2000 to conduct research on developing sustainable biotech products for public welfare. It currently has various ongoing research projects and provides training programs to develop skilled researchers. The NIB aims to commercialize technologies and transfer innovations to industries for the nation's benefit.PEGS Boston the essential protein engineering summit
PEGS Boston the essential protein engineering summitNicole Proulx
Ìý
With record-breaking attendance in 2015, PEGS Boston attracts an international delegation of nearly 2,000 participants including conference delegates, speakers, exhibitors, sponsors and guests representing over 30 countries.
Participants value the in-depth short courses, access to 22 conferences, and wide-ranging presentations delivering new unpublished data, case studies, innovation and insight.
The vast exhibit hall will be packed with 125 exhibiting companies and more than 200 research posters on display providing valuable viewing of innovative new technologies, as well as abundant networking with biopharma researchers and industry representatives.Information Brochure of ILS
Information Brochure of ILSRaam Mishra
Ìý
Innovation LifeSciences (ILS) is a multidisciplinary research organization established in 2012 at the Natural Science Research Institute campus in Lucknow, India. ILS conducts research in various fields of life sciences and has a team of professionals with expertise in areas like biotechnology, nanotechnology, and plant sciences. ILS also offers training programs for young professionals to gain hands-on experience in advanced lab techniques in fields like molecular biology, biotechnology, and bioinformatics.Food Safety 2016 new brouchure
Food Safety 2016 new brouchureHarika B
Ìý
This document provides information about the 2nd International Conference on Food Safety and Regulatory Measures being held June 6-8, 2016 in London, UK. The conference will include keynote lectures, oral and poster presentations on various topics related to food safety. Registration options include e-posters, student delegates, and group registrations. There will be best poster and young researcher awards. Speakers will discuss topics like food safety regulations, food quality and processing, and food security. The deadline for abstract submissions is March 30, 2016.SMi's 5th annual Pharmaceutical Microbiology
SMi's 5th annual Pharmaceutical MicrobiologyAnna Serazetdinova
Ìý
Taking place on the 20th and 21st January 2016, London UK, Pharmaceutical Microbiology event will provide essential insights in to the latest advancements in practice and technology, developments in regulation and harmonisation of international practice and evolving methods and the latest technology.
Join us as we explore key issues in data review and analysis, contamination control strategies, strategies for low endotoxin recovery and best practice in sterile and non-sterile manufacture. Gain an in-depth insight into endotoxin testing, validation and LER. Understand the threats posed by VBNCs and how to detect them.
For more information or to register for this conference please visit:
www.pharma-microbiology.com/lin
Book by 30th October and save £200!
Book by 30th November and save £100!
SMi Group's 5th annual Pharmaceutical Microbiology 2016 conference
SMi Group's 5th annual Pharmaceutical Microbiology 2016 conferenceDale Butler
Ìý
SMi Group's Pharmaceutical Microbiology 2016 conference returns to London for its 5th year next JanuaryMore Related Content
Similar to ABALL_ASM (20)
Biofest events organised by the Victorian Government
Biofest events organised by the Victorian GovernmentAndrew Wear
Ìý
As the State sponsor we invite registered delegates to consider attending some of the Victorian Government organised Biofest events.Microbion_nutraceuticals_emailing
Microbion_nutraceuticals_emailingAntonio Del Casale
Ìý
Microbion offers analytical, research and development, and bio-bank services for nutraceutical companies. Their services include genomic analysis of microorganisms used in probiotics and fermented foods, as well as assessing genetic stability, purity, safety, and validating health claims. Microbion can also authenticate strains using DNA fingerprinting and develop diagnostic methods and protocols tailored for specific customer strains or formulations.MRADUS16-PBCUS16_Agenda
MRADUS16-PBCUS16_AgendaKatarina Kadovic
Ìý
The document provides information about the 4th Microbiome R&D and Business Collaboration Forum and Probiotics Congress that will take place from 3-4 October 2016 in La Jolla, San Diego. The conference will explore research on the human microbiome and its role in health and disease, as well as commercial opportunities. Over 250 attendees are expected, including leading academics and industry experts who will give presentations on topics like gut and skin microbiota, probiotics, and commercializing microbiome research. The schedule provides details on speakers, session topics, sponsors, and arrangements.InfectionPrevention_AtulSingh
InfectionPrevention_AtulSinghAtul Kumar Singh, PhD
Ìý
Healthcare-associated infections are a major public health problem worldwide and a leading cause of death in hospitals. Antimicrobial resistance poses a serious threat as many antibiotics are becoming ineffective. Disinfection and sanitization are important first lines of defense against disease-causing microbes. However, research and development of new and effective disinfectants has been limited by a lack of funding and public perception of disinfectants as non-essential. Increased investment in disinfectant research and ensuring proper use and training are needed to address the growing risks of antibiotic resistance.Quality In Biopharma Press Release
Quality In Biopharma Press ReleaseStewart K. Jason
Ìý
The second annual North Carolina Quality in Biopharma Conference will be held May 20-21, 2010 at the Bioprocessing Technical Education Center at North Carolina State University's Centennial Campus in Raleigh, North Carolina. The focus of the two-day event will be environmental monitoring in biomanufacturing, with talks, discussions, and networking for professionals in quality, manufacturing, environmental microbiology, and process engineering. James C. Greenwood, president and CEO of the Biotechnology Industry Organization, will speak about how the biotechnology industry is being impacted by legislation and shaped by public policy.Pharmaceutical microbiology west coast
Pharmaceutical microbiology west coastAlia Malick
Ìý
SMi will host the 7th Pharmaceutical Microbiology West Coast conference on June 8-9, 2017 in San Diego, USA. The conference will address current challenges in sterility assurance, environmental monitoring, and rapid microbial methods. Over the two days, experts from companies like GSK, Amgen, Janssen, and Takeda will discuss topics like environmental monitoring trends and data analysis, challenges in endotoxin testing and sterility assurance, case studies on contamination control, and the validation and use of rapid microbial methods. Workshops on the day before will cover technologies for monitoring contamination control and case studies, as well as microbial requirements for terminal sterilization.2011 October - PCT News Discovery Starts With Sample Preparation
2011 October - PCT News Discovery Starts With Sample PreparationPressure BioSciences, Inc.
Ìý
This document discusses presentations made by independent researchers at scientific conferences highlighting the advantages of Pressure Cycling Technology (PCT) developed by Pressure BioSciences, Inc. It notes that PCT allows faster and improved sample processing for applications such as biomarker discovery. Pressure BioSciences believes increased awareness and acceptance of PCT will lead to increased revenue in the second half of 2011 compared to the first half. The company is working to commercialize new PCT-based instruments and raise capital to support sales and marketing efforts.SMi Group's Superbugs and Superdrugs 2020 conference
SMi Group's Superbugs and Superdrugs 2020 conferenceDale Butler
Ìý
This document provides information about the Superbugs & Superdrugs conference on March 30-31, 2020 in London. The conference will focus on non-traditional approaches to fighting antimicrobial resistance and will feature speakers from companies and organizations working on alternatives to antibiotics, including those developing antibacterial proteins, agents that neutralize bacterial virulence, direct lytic agents, and immunomodulatory therapies. It provides details on the agenda, speakers, workshops, registration and sponsorship opportunities.BeneficialMicrobes-2015_Brochure
BeneficialMicrobes-2015_BrochureJames Roberts
Ìý
This document provides information about the "Beneficial Microbes-2015" conference to be held in Valencia, Spain from August 25-27, 2015. The conference will focus on exploiting the power of microbes for industrial development. It will include presentations from experts in various fields related to beneficial microbes. Participants can attend speaker sessions, workshops, poster presentations, and networking events. The conference aims to bring together academics, industry professionals, and public health experts to discuss the latest research and applications of beneficial microbes.CHI's Immunogenicity & Bioassay Summit 2018
CHI's Immunogenicity & Bioassay Summit 2018James Prudhomme
Ìý
This document provides information about the 10th Annual Immunogenicity & Bioassay Summit taking place from October 22-25, 2018 in Washington, DC. It will include conferences on immunogenicity assessment and clinical relevance, immunogenicity prediction and control, and optimizing bioassays for biologics. There will also be a symposium on immunology for biotherapeutics and a training seminar on design of experiments. The summit brings together industry, academia, and regulatory authorities to discuss challenges in the field. It provides opportunities for networking, learning about new expectations, and hearing from thought leaders and regulators.India's first Int'l Conference on Best Practices in Pharma Microbiology
India's first Int'l Conference on Best Practices in Pharma Microbiology Biocon
Ìý
This is the first time that Pharmig, an international Pharmaceutical Microbiology think tank based out of the UK is organizing a conference on the "Best Practices in Pharma Microbiology" for the first time in India. You can register
by sending an email to maxine@pharmig.org.uk. For booking a seat for the conference, please visit: http://bit.ly/1J4gtLhBiobanking 2010 Ta
Biobanking 2010 Tatatisalla
Ìý
The document announces a conference on biobanking to be held on February 4-5, 2010 in London. It will examine trends in the biobanking industry and address challenges in areas like ethics, regulation, and cost-effectiveness. Key speakers will discuss developing biobanks, patient involvement, and data protection. Attendees can network with leaders from pharma, biotech, healthcare, and regulatory agencies. The conference aims to provide an in-depth understanding of opportunities and advancements in biobanking.Biosimilars 2012
Biosimilars 2012Omics Publishing Group
Ìý
The International Conference and Exhibition on Biowaivers & Biosimilars will be held September 10-12, 2012 in San Antonio, Texas. The goal is to educate participants on national and international initiatives affecting biosimilar drug development and procedures to waive bioequivalence studies. Topics will include biosimilars regulation, clinical studies, commercialization, and biowaivers based on biopharmaceutics classification systems and in vitro-in vivo correlation. The conference aims to further understanding of continuous efforts to improve biosimilar quality and use of biowaivers to make bioequivalence studies more cost effective.Conferences
ConferencesOMICS Group | International Science Conferences
Ìý
OMICS Group aims at creating collaboration between the various members of the scientific community through a common platform. This enables exchange of the latest developments by delegates at the OMICS Group conference, which is split into several tracks and themes according to the requirements. The perspective of OMICS Group in organizing the events yields a common objective to meet and discuss the most happening developments in the relevant domain.National institue of biotechnology
National institue of biotechnologyAbirHasanJoy1
Ìý
The National Institute of Biotechnology (NIB) in Bangladesh has several research divisions focused on important areas:
- Environmental Biotechnology studies arsenic contamination and bioremediation.
- Microbial Biotechnology develops enzymes for industries and studies diseases.
- Plant Biotechnology works on crops and detects potato diseases.
- Molecular Biotechnology examines human diseases like diabetes.
The NIB was established in 2000 to conduct research on developing sustainable biotech products for public welfare. It currently has various ongoing research projects and provides training programs to develop skilled researchers. The NIB aims to commercialize technologies and transfer innovations to industries for the nation's benefit.PEGS Boston the essential protein engineering summit
PEGS Boston the essential protein engineering summitNicole Proulx
Ìý
With record-breaking attendance in 2015, PEGS Boston attracts an international delegation of nearly 2,000 participants including conference delegates, speakers, exhibitors, sponsors and guests representing over 30 countries.
Participants value the in-depth short courses, access to 22 conferences, and wide-ranging presentations delivering new unpublished data, case studies, innovation and insight.
The vast exhibit hall will be packed with 125 exhibiting companies and more than 200 research posters on display providing valuable viewing of innovative new technologies, as well as abundant networking with biopharma researchers and industry representatives.Information Brochure of ILS
Information Brochure of ILSRaam Mishra
Ìý
Innovation LifeSciences (ILS) is a multidisciplinary research organization established in 2012 at the Natural Science Research Institute campus in Lucknow, India. ILS conducts research in various fields of life sciences and has a team of professionals with expertise in areas like biotechnology, nanotechnology, and plant sciences. ILS also offers training programs for young professionals to gain hands-on experience in advanced lab techniques in fields like molecular biology, biotechnology, and bioinformatics.Food Safety 2016 new brouchure
Food Safety 2016 new brouchureHarika B
Ìý
This document provides information about the 2nd International Conference on Food Safety and Regulatory Measures being held June 6-8, 2016 in London, UK. The conference will include keynote lectures, oral and poster presentations on various topics related to food safety. Registration options include e-posters, student delegates, and group registrations. There will be best poster and young researcher awards. Speakers will discuss topics like food safety regulations, food quality and processing, and food security. The deadline for abstract submissions is March 30, 2016.SMi's 5th annual Pharmaceutical Microbiology
SMi's 5th annual Pharmaceutical MicrobiologyAnna Serazetdinova
Ìý
Taking place on the 20th and 21st January 2016, London UK, Pharmaceutical Microbiology event will provide essential insights in to the latest advancements in practice and technology, developments in regulation and harmonisation of international practice and evolving methods and the latest technology.
Join us as we explore key issues in data review and analysis, contamination control strategies, strategies for low endotoxin recovery and best practice in sterile and non-sterile manufacture. Gain an in-depth insight into endotoxin testing, validation and LER. Understand the threats posed by VBNCs and how to detect them.
For more information or to register for this conference please visit:
www.pharma-microbiology.com/lin
Book by 30th October and save £200!
Book by 30th November and save £100!
SMi Group's 5th annual Pharmaceutical Microbiology 2016 conference
SMi Group's 5th annual Pharmaceutical Microbiology 2016 conferenceDale Butler
Ìý
SMi Group's Pharmaceutical Microbiology 2016 conference returns to London for its 5th year next JanuaryABALL_ASM
- 1. Contact | Sitemap Search: 800.458.4141 NEWS & EVENTS INDUSTRY EVENTS AND TRADE SHOWS PREVIOUS EVENTS AND TRADESHOWS NEWS & EVENTS Toxikon to Exhibit at the American Society for Microbiology Conference Toxikon will be exhibiting at the 114th General Meeting for American Society for Microbiology (ASM), May 18 - 20, at the Boston Convention and Exhibition Center. Visit us at booth #342. Our Study Director, Anthony Ball, will also be participating at the asm2014 Mentoring Breakfast (Tuesday, May 20, 8 - 10 am). He will be serving as a mentor on the following topic: Careers in Industry. At Toxikon, Anthony manages microbiology studies leading to product registration. He develops new test procedures and associated validations and services. His area of expertise includes antimicrobial drug discovery and validation of medical devices. About ASM 2014 asm2014 is the 114th General Meeting of the American Society for Microbiology. Held at the Boston Convention & Exhibition Center, this year's meeting will showcase the central role of microbes in the biosphere by communicating today's cutting edge science in the diverse areas of microbiology through a wide range of interactive workshops, scientific sessions, and networking events. Learn, connect, and be inspired by the best. Join your peers at the world’s largest meeting of microbiologists, asm2014. About Toxikon's Microbiology Department Toxikon’s Microbiology Department effectively collaborates with clients to develop customized study protocols that meet your requirements. Our staff of experienced microbiologists apply their technical expertise when conducting each study to generate timely, quality data to your program’s requirements. Our services include, but are not limited to: Routine Lot Release Programs Bioburden Determination Endotoxin Evaluation Sterility Testing Additionally, we provide non-routine studies, including reusable device processing (cleaning, disinfection, and sterilization), validations, microbial or viral ingress assessments, antimicrobial efficacy, as well as packaging, product shelf life and life cycle validations. To learn more, please browse our website. Hope to see you in Boston! You may also contact us at 800.458.4141 or info@toxikon.com. All current news releases Want to learn more? Click here to contact us. ABOUT US QUALITY & REGULATORY SERVICES PARTNERS RESOURCES CAREERS NEWS & EVENTS Preclinical CRO | Global Contract Research Company | P... http://www.toxikon.com/news-events/index.cfm?id=Toxiko... 1 of 2 10/5/14 3:32 PM
- 2. About Us | Quality & Regulatory | Services | Partners | Resources | Careers | News & Events | Contact | Sitemap | Legal | Site Credits ©2010 Toxikon, Inc. Preclinical CRO | Global Contract Research Company | P... http://www.toxikon.com/news-events/index.cfm?id=Toxiko... 2 of 2 10/5/14 3:32 PM